Pentostatin
Thông số
53910-25-1Số CAS
637-271-5Số EC
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-olTên IUPAC
C11H16N4O4Công thức hóa học
268.27 g/molKhối lượng phân tử
pentostatin; Deoxycoformycin; 53910-25-1; Nipent; Pentostatina; Pentostatine; Pentostatinum; 2'-DCF; CO-Vidarabine; CI-825; YK-176; NSC-218321; PD 81565; PD-81565; DTXSID2023436; 395575MZO7; DTXCID403436; CI 825; (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol; NSC218321; NSC 218321; (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol; (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol; CL 67310465; (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol; Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-; (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,4H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol; (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,6H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol; (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-7,8-dihydro-4H-imidazo(4,5-d)(1,3)diazepin-8-ol; (R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol; 2' Deoxycoformycin; RefChem:57393; L01XX08; CI825; 637-271-5; Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-; Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-; Covidarabine; PD-ADI; 2'-Dexoycoformycin; Vira A deaminase inhibitor; MFCD00078802; (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol; (R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol; NCGC00182045-01; Deaminase inhibitor (PD); dCF; (R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol; (R)-2'-Deoxycoformycin; (R)-Deoxycoformycin; CI-825;Deoxycoformycin; 8R-2'-Deoxycoformycin; Pentostatine [INN-French]; Pentostatinum [INN-Latin]; Pentostatina [INN-Spanish]; Pentostatin (JAN/USAN/INN); UNII-395575MZO7; CL-67310465; HSDB 6547; Pentostatin [USAN:INN:BAN:JAN]; Pentostatin (PTN); BRN 1223097; Pentostatin (Standard); PENTOSTATIN [MI]; PENTOSTATIN [INN]; PENTOSTATIN [JAN]; Deaminase, inhibitor for adenosine arabinoside; PENTOSTATIN [HSDB]; PENTOSTATIN [USAN]; PENTOSTATIN [VANDF]; SCHEMBL2817; CHEMBL1580; PENTOSTATIN [MART.]; PENTOSTATIN [WHO-DD]; BIDD:GT0136; GTPL4805; SCHEMBL1649740; BDBM22925; CHEBI:27834; HY-A0006R; Pentostatin, >=95% (HPLC); PENTOSTATIN [ORANGE BOOK]; BDBM223291; GLXC-05480; HY-A0006; Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-; Tox21_113417; EBC-08665; MSK164430; s9521; AKOS024456918; AKOS032949742; AD03945; CS-0374; DB00552; NCGC00388420-02; (8R)-3-(2-Deoxy-?-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol; Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-; CAS-53910-25-1; NS00005086; C02267; D00155; EN300-222177; Q425470; SR-01000883935; SR-01000883935-1; BRD-K91543828-001-02-0; Z2204459563; (8R)-3-(2-Deoxy-b-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol; (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-8-ol; (R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-olTên gọi khác
